Cancer in the current context of the Covid-19 Pandemic
International Journal of Development Research
Cancer in the current context of the Covid-19 Pandemic
Received 27th May 2020; Received in revised form 11th June 2020; Accepted 09th July 2020; Published online 30th August 2020
Copyright © 2020, Bruno Viana Rosa et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
The new coronavirus disease (Covid-19) emerged in December 2019 in Wuhan, China, and quickly spread around the world. Cancer is regarded to be one of the leading causes of premature death in most countries and correlated with an increased risk for complications in patients infected with Covid-19. Thus, the aim of this study was to inform whether cancer is a predominant factor in the mortality rate from SARS-CoV-2 infection. This study is a narrative review based on a bibliographic survey in the databases PubMed, SCOPUS, Web of Science and Cochrane. The results show that Covid-19 is a public health problem that can aggravate cancer due to its association with worsening of prognosis of the pathology. Randomized clinical trials and large population studies should be conducted in order to better elucidate this issue and show the relationship of cancer in complications and mortality rate in patients with Covid-19.
